¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©
¼¶±ð: ²©Ê¿
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-20   

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© (WW*yv.J  
NT qtr="  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© /3MTutM|<X  
  1¡¢Co-stimulators (or co-stimulating molecules) R"j6 w[tn  
  2¡¢NK-kB 6usy0g D  
  3¡¢Immunoglobulin superfamily t>04nN_@,s  
  4¡¢antigen-presenting cell (APC) o6H\JCne  
  5¡¢death domain V}leEf2'  
  6¡¢CCR and CXCR <"SDU_<xG  
  7¡¢Lectin (or mitogen) l7rGz2:?  
  8¡¢Clusters of differentiation, CD) 'rT@ r:6fn  
  9¡¢B7 family ? J;*  
  10¡¢Cytotoxic T lymphocyte, CTL) f8>S<:  
  11¡¢IL-15 and IL-15 receptor (IL-15R) $6~ \xe=  
  12¡¢MHC restriction 1[QH68  
  13¡¢Affinity-chromatography lX)RG*FlTC  
  14¡¢Cyctosprin A, CsA %-zAV*>  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) #MZ0Sd8]&  
W] 8tp@  
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© QK+s}ny  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 4o:  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ X%+FM]  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ w|6;Pf~1y)  
7e,EI9?.  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© G$ l>By  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ L{>XT  
  ѪҺ²¡Ñ§×¨Òµ£º yFt'<{z[nL  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»